Clinical Trial Update: A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy, safety, and pharmacokinetics of subcutaneous octreotide in patients with gastroenteropancreatic neuroendocrine t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteropancreatic Neuroendocrine Tumor

Drugs mentioned

• Octreotide (subcutaneous injection) (octreotide)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Gastrointestinal Neuroendocrine Pancreatic Tumor | Phase 2 | Status: RECRUITING